AFJK Aimei Health Technology Co., Ltd
Financial Services$40.06-1.35%ClosedMarket Cap: $245.2M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
243.87
PEG
—
P/B
20.16
P/S
0.00
EV/EBITDA
-295.85
DCF Value
$-0.50
FCF Yield
-0.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
3.2%
ROA
8.8%
ROIC
-7.8%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 null | $0.00 | $98.1K | $— |
| FY null | $0.00 | $1.1M | $— |
| Q3 null | $0.00 | $352.0K | $— |
| Q2 null | $0.00 | $425.0K | $— |
Trading Activity
Insider Trades
View AllMIZUHO SECURITIES USA LLC10 percent owner
SellTue Feb 11
MIZUHO SECURITIES USA LLC10 percent owner
SellTue Feb 11
Company Info
Sector
Financial Services
Industry
Shell Companies
Country
US
Exchange
—
Beta
0.46
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.